Abstract:Key PointsThe development of the next generation of nanoparticle therapeutics — based on polymeric nanoparticles that combine the pre-eminent features of traditional delivery vectors such as liposomes and polymer-drug conjugates, but offer new flexibility to overcome some of the key barriers in the field — is gaining momentum.To achieve intracellular drug delivery, strategies for overcoming various biological barriers — from the system level, to the organ level and to the cellular level — are needed. For intravenously injected engineered nanoparticles, the avoidance of multiple organ-level clearance mechanisms, such as those operating in the spleen and in the liver, must be compensated for if the carrier is to reach its intended destination. Ultimately, the effectiveness of any engineered nanoparticle will depend on the efficiency of the carrier to deliver its cargo to the intracellular site of action, which in many cases requires organelle-specific targeting.The size, the surface characteristics and the shape of a nanoparticle have a key role in its biodistribution in vivo. The effects of size have been studied extensively with spherically shaped particles and some general trends have been noted. Particle size is also known to influence the mechanism of cellular internalization. However, current findings indicate that particle shape is just as important, if not more so, than size in controlling key aspects of both biodistribution and nanoparticle internalization.Achieving tailored activated release of therapeutic cargo still represents a key barrier in the field of engineered nanoparticles. The predominant strategies so far incorporate materials that are enzymatically degradable, pH sensitive or reductively labile, which facilitate bond breaking between the drug and the carrier, or destabilization of the carrier on reaching the intended site of action.

Non-spherical Polymeric Nanocarriers for Therapeutics: The Effect of Shape on Biological Systems and Drug Delivery Properties

Self-assembled carriers as drug delivery systems: Current characterization challenges and future prospects

Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications

Regulation the Morphology of Micro-and Nanoparticles and the Effect on Drug/Gene Delivery System

Self-assembled polymer nanostructures for delivery of anticancer therapeutics

Shape Dependent Therapeutic Potential of Nanoparticulate System: Advance Approach for Drug Delivery

Effects of morphology and size of nanoscale drug carriers on cellular uptake and internalization process: a review

Combining Nanoparticle Shape Modulation and Polymersome Technology in Drug Delivery

A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems

Polymeric Micelles As Nanocarriers for Drug Delivery

Form Follows Function: Nanoparticle Shape and Its Implications for Nanomedicine

Strategies in the design of nanoparticles for therapeutic applications

Shape Effects of Cylindrical Versus Spherical Unimolecular Polymer Nanomaterials on in Vitro and in Vivo Behaviors.

Effects of Particle Geometry for PLGA-Based Nanoparticles: Preparation and In Vitro/In Vivo Evaluation

Rational design of polymeric micelles for targeted therapeutic delivery

Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery

Nanomaterial Strategies for Delivery of Therapeutic Cargoes

Designing Natural Polymer-Based Capsules and Spheres for Biomedical Applications—A Review

Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine

Polymer Vesicles and Lipid Nanoparticles

Translatable High Drug Loading Drug Delivery Systems Based on Biocompatible Polymer Nanocarriers.